Skip to main content

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Nataliya Uboha, MD, PhD
Conference Coverage
06/20/2024
Nataliya Uboha, MD, PhD
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Nataliya Uboha, MD, PhD, discusses the role cytoreductive surgery with HIPEC has for patients with gastric cancers that have peritoneal carcinomatosis.
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Nataliya Uboha, MD, PhD, discusses the role cytoreductive surgery with HIPEC has for patients with gastric cancers that have peritoneal carcinomatosis.
At Great Debates and Updates in...
06/20/2024
Oncology
Nataliya Uboha, MD, PhD
Conference Coverage
06/20/2024
Nataliya Uboha, MD, PhD
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Nataliya Uboha, MD, PhD, discusses the role immunotherapy can have in the treatment of patients with microsatellite instability.
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Nataliya Uboha, MD, PhD, discusses the role immunotherapy can have in the treatment of patients with microsatellite instability.
At Great Debates and Updates in...
06/20/2024
Oncology
Michael Overman, MD
Conference Coverage
06/20/2024
Michael Overman, MD
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Michael Overman, MD, explores whether or not there is a role for immune therapy in the treatment of patients with proficient mismatch repair colorectal...
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Michael Overman, MD, explores whether or not there is a role for immune therapy in the treatment of patients with proficient mismatch repair colorectal...
At Great Debates and Updates in...
06/20/2024
Oncology
Michael Overman, MD
Conference Coverage
05/24/2024
Michael Overman, MD
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Michael Overman, MD, discussed advantages associated with treating patients with MSI-high colorectal cancer with doublet immunotherapy.
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Michael Overman, MD, discussed advantages associated with treating patients with MSI-high colorectal cancer with doublet immunotherapy.
At Great Debates and Updates in...
05/24/2024
Oncology
Michael Lidsky, MD
Conference Coverage
05/24/2024
Michael Lidsky, MD
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Michael Lidsky, MD, discussed ways researchers are working to overcome barriers to hepatic arterial infusion pump therapy limitations for patients with...
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Michael Lidsky, MD, discussed ways researchers are working to overcome barriers to hepatic arterial infusion pump therapy limitations for patients with...
At Great Debates and Updates in...
05/24/2024
Oncology
Michael Hall, MD
Conference Coverage
05/24/2024
Michael Hall, MD
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Michael Hall, MD, MS, discussed limitations to performing germline genetic testing on all patients with gastrointestinal cancers.
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Michael Hall, MD, MS, discussed limitations to performing germline genetic testing on all patients with gastrointestinal cancers.
At Great Debates and Updates in...
05/24/2024
Oncology
Adam Talenfeld, MD
Conference Coverage
05/23/2024
Adam Talenfeld, MD
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Adam Talenfeld, MD, argued in favor of using transarterial chemoembolization alongside immune checkpoint blockade to treat patients with hepatocellular...
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Adam Talenfeld, MD, argued in favor of using transarterial chemoembolization alongside immune checkpoint blockade to treat patients with hepatocellular...
At Great Debates and Updates in...
05/23/2024
Oncology
James Harding, MD
Conference Coverage
05/22/2024
James Harding, MD
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, James Harding, MD, discussed results from the EMERALD-1 study which demonstrated that transarterial chemoembolization plus immune checkpoint blockade...
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, James Harding, MD, discussed results from the EMERALD-1 study which demonstrated that transarterial chemoembolization plus immune checkpoint blockade...
At Great Debates and Updates in...
05/22/2024
Oncology
Jennifer Wo, MD
Conference Coverage
05/21/2024
Jennifer Wo, MD
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Jennifer Wo, MD, discussed use of long course neoadjuvant radiation therapy for the treatment of patients with rectal cancer.
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Jennifer Wo, MD, discussed use of long course neoadjuvant radiation therapy for the treatment of patients with rectal cancer.
At Great Debates and Updates in...
05/21/2024
Oncology
Ryan Moy, MD
Conference Coverage
05/18/2024
Ryan Moy, MD
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Ryan Moy, MD, PhD, discussed first-line use of PD-1 inhibitors for the treatment of patients with gastroesophageal cancers.
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Ryan Moy, MD, PhD, discussed first-line use of PD-1 inhibitors for the treatment of patients with gastroesophageal cancers.
At Great Debates and Updates in...
05/18/2024
Oncology
Samuel Cytryn, MD
Conference Coverage
05/18/2024
Samuel Cytryn, MD
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Samuel Cytryn, MD, discussed first-line use of claudin-18.2 inhibitors for patients with gastroesophageal cancers.
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Samuel Cytryn, MD, discussed first-line use of claudin-18.2 inhibitors for patients with gastroesophageal cancers.
At Great Debates and Updates in...
05/18/2024
Oncology
Nataliya Uboha, MD, Carbone Cancer Center
Videos
09/29/2023
At the Great Debates & Updates in Gastrointestinal Malignancies meeting, Nataliya Uboha, MD, PhD, discusses the use of biomakers to choose the best treatment for patients with upper GI cancers.
At the Great Debates & Updates in Gastrointestinal Malignancies meeting, Nataliya Uboha, MD, PhD, discusses the use of biomakers to choose the best treatment for patients with upper GI cancers.
At the Great Debates & Updates...
09/29/2023
Oncology
Aparna Parikh, MD, MGH Cancer Center
Videos
09/28/2023
At the Great Debates & Updates in Gastrointestinal Malignancies meeting, Aparna Parikh, MD, presented on the role circulating tumor DNA may have in the treatment of patients with colorectal cancer.
At the Great Debates & Updates in Gastrointestinal Malignancies meeting, Aparna Parikh, MD, presented on the role circulating tumor DNA may have in the treatment of patients with colorectal cancer.
At the Great Debates & Updates...
09/28/2023
Oncology
Joseph Herman, MD, Northwell Health Cancer Institute
Videos
04/20/2023
At the 2023 Great Debates and Updates in Gastrointestinal Malignancies meeting, Joseph Herman, MD, discussed the argument against use of radiotherapy in borderline resectable pancreas cancer.
At the 2023 Great Debates and Updates in Gastrointestinal Malignancies meeting, Joseph Herman, MD, discussed the argument against use of radiotherapy in borderline resectable pancreas cancer.
At the 2023 Great Debates and...
04/20/2023
Oncology
Anup Kasi, MD, University of Kansas Cancer Center
Videos
04/20/2023
Anup Kasi, MD, discusses the debate on neoadjuvant vs adjuvant immunotherapy for patients with locally advanced HER2-positive upper gastrointestinal tract cancers, held at the 2023 Great Debates and Updates in GI Malignancies in Chicago.
Anup Kasi, MD, discusses the debate on neoadjuvant vs adjuvant immunotherapy for patients with locally advanced HER2-positive upper gastrointestinal tract cancers, held at the 2023 Great Debates and Updates in GI Malignancies in Chicago.
Anup Kasi, MD, discusses the...
04/20/2023
Oncology
Arvind Dasari, MD, MD Anderson Cancer Center
Videos
04/13/2023
Arvind Dasari, MD, reviews the new and upcoming treatment options for patients with neuroendocrine tumors at the 2023 Great Debates and Updates in GI Malignancies in Chicago.
Arvind Dasari, MD, reviews the new and upcoming treatment options for patients with neuroendocrine tumors at the 2023 Great Debates and Updates in GI Malignancies in Chicago.
Arvind Dasari, MD, reviews the...
04/13/2023
Oncology
Anup Kasi, MD, University of Kansas Cancer Center
Videos
04/12/2023
At the 2023 GDU GI meeting, Anup Kasi, MD, participating in a debate on treatment options for patients with microsatellite instability-high locally resectably gastric or gastroesophageal junction adenocarcinoma.
At the 2023 GDU GI meeting, Anup Kasi, MD, participating in a debate on treatment options for patients with microsatellite instability-high locally resectably gastric or gastroesophageal junction adenocarcinoma.
At the 2023 GDU GI meeting, Anup...
04/12/2023
Oncology
Milind Javle, MD, MD Anderson Cancer Center
Videos
04/12/2023
At the 2023 Great Debates and Updates in GI Malignancies, Milind Javle, MD, discusses the recent developments in the treatment of patients with cholangiocarcinoma.
At the 2023 Great Debates and Updates in GI Malignancies, Milind Javle, MD, discusses the recent developments in the treatment of patients with cholangiocarcinoma.
At the 2023 Great Debates and...
04/12/2023
Oncology
Milind Javle, MD, MD Anderson Cancer Center
Videos
04/06/2023
While at the 2023 Great Debates and Updates in GI Malignancies meeting in Chicago, Milind Javle, MD, reviews the latest FDA approvals in the cholangiocarcinoma space.
While at the 2023 Great Debates and Updates in GI Malignancies meeting in Chicago, Milind Javle, MD, reviews the latest FDA approvals in the cholangiocarcinoma space.
While at the 2023 Great Debates...
04/06/2023
Oncology
Sonia Kupfer, MD, University of Chicago
Videos
04/01/2023
At the 2023 Great Debates & Updates in Gastrointestinal Malignancies in Chicago, regional co-chair Sonia Kupfer, MD, discussed the significant part that genetics play when treating patients with gastrointestinal cancers.
At the 2023 Great Debates & Updates in Gastrointestinal Malignancies in Chicago, regional co-chair Sonia Kupfer, MD, discussed the significant part that genetics play when treating patients with gastrointestinal cancers.
At the 2023 Great Debates &...
04/01/2023
Oncology
Anjee Davis, MPPA, Fight Colorectal Cancer
Videos
04/01/2023
At the 2023 Great Debates & Updates in Gastrointestinal Malignancies in Chicago, President of Fight Colorectal Cancer, Anjee Davis, MPPA, shares the importance of patient advocacy and how clinicians can help support and empower their patients...
At the 2023 Great Debates & Updates in Gastrointestinal Malignancies in Chicago, President of Fight Colorectal Cancer, Anjee Davis, MPPA, shares the importance of patient advocacy and how clinicians can help support and empower their patients...
At the 2023 Great Debates &...
04/01/2023
Oncology
Gary Deng, MD, Memorial Sloan Kettering Cancer Center
Videos
04/01/2023
At the 2023 Great Debates and Updates in Gastrointestinal Cancers meeting in Chicago, Gary Deng, MD, PhD, highlighted the pillars of cancer wellness and explained how to incorporate integrative medicine into the management of patients with...
At the 2023 Great Debates and Updates in Gastrointestinal Cancers meeting in Chicago, Gary Deng, MD, PhD, highlighted the pillars of cancer wellness and explained how to incorporate integrative medicine into the management of patients with...
At the 2023 Great Debates and...
04/01/2023
Oncology
Suneel Kamath, MD, Cleveland Clinic
Videos
03/31/2023
Suneel Kamath, MD, gives an overview of his talk on circulating tumor DNA from the 2023 Great Debates and Updates in Gastrointestinal Malignancies meeting in Chicago, IL.
Suneel Kamath, MD, gives an overview of his talk on circulating tumor DNA from the 2023 Great Debates and Updates in Gastrointestinal Malignancies meeting in Chicago, IL.
Suneel Kamath, MD, gives an...
03/31/2023
Oncology
Nataliya Uboha, MD, PhD, University of Wisconsin
Videos
03/30/2023
At the 2023 Great Debates and Updates in Gastrointestinal Malignancies in Chicago, Nataliya Uboha, MD, PhD, gave an overview of her presentation on biomarkers and targeting treatment for gastroesophageal cancers.
At the 2023 Great Debates and Updates in Gastrointestinal Malignancies in Chicago, Nataliya Uboha, MD, PhD, gave an overview of her presentation on biomarkers and targeting treatment for gastroesophageal cancers.
At the 2023 Great Debates and...
03/30/2023
Oncology
Michael Hall, MD, Fox Chase Cancer Center
Podcasts
12/20/2022
Michael Hall, MD, reviews his presentation from the 2022 Great Debates & Updates in Gastrointestinal Malignancies virtual meeting, on genetic testing for gastrointestinal cancers.
Michael Hall, MD, reviews his presentation from the 2022 Great Debates & Updates in Gastrointestinal Malignancies virtual meeting, on genetic testing for gastrointestinal cancers.
Michael Hall, MD, reviews his...
12/20/2022
Oncology
Gary Deng, MD, Memorial Sloan Kettering Cancer Center
Videos
12/20/2022
At the 2022 Great Debates & Updates in Gastrointestinal Malignancies virtual meeting, Gary Deng, MD, discusses modes of complementary medicine that patients with gastrointestinal cancers may be curious about.
At the 2022 Great Debates & Updates in Gastrointestinal Malignancies virtual meeting, Gary Deng, MD, discusses modes of complementary medicine that patients with gastrointestinal cancers may be curious about.
At the 2022 Great Debates &...
12/20/2022
Oncology
Dr M
Podcasts
03/30/2022
Van Morris, MD, MD Anderson Cancer Center, discusses the evolving roles of KRAS inhibitors in CRC.
Van Morris, MD, MD Anderson Cancer Center, discusses the evolving roles of KRAS inhibitors in CRC.
Van Morris, MD, MD Anderson...
03/30/2022
Oncology
Dr Morris
03/30/2022
Dr Morris highlights the role of tumor mutation burden at the 2022 GDU GI Annual Meeting.
Dr Morris highlights the role of tumor mutation burden at the 2022 GDU GI Annual Meeting.
Dr Morris highlights the role of...
03/30/2022
Oncology
Dr Morris
Podcasts
03/30/2022
Van Morris, MD, reviews emerging targeted therapies for patients with metastatic colorectal cancer.
Van Morris, MD, reviews emerging targeted therapies for patients with metastatic colorectal cancer.
Van Morris, MD, reviews emerging...
03/30/2022
Oncology
Vivian Strong, MD, Memorial Sloan Kettering Cancer Center
Videos
03/30/2022
Vivian Strong, MD, discusses the need of surgeons working more closely with medical oncologists, GI experts, and basic scientists in order to push novel approaches forward for gastric cancer treatment.
Vivian Strong, MD, discusses the need of surgeons working more closely with medical oncologists, GI experts, and basic scientists in order to push novel approaches forward for gastric cancer treatment.
Vivian Strong, MD, discusses the...
03/30/2022
Oncology
Vivian Strong, MD, Memorial Sloan Kettering Cancer Center
Videos
03/30/2022
Vivian Strong, MD, discusses clinical trials of interest within the surgical field of gastric and GEJ cancers, presented at the 2022 GDU GI Annual Meeting.
Vivian Strong, MD, discusses clinical trials of interest within the surgical field of gastric and GEJ cancers, presented at the 2022 GDU GI Annual Meeting.
Vivian Strong, MD, discusses...
03/30/2022
Oncology
Vivian Strong, MD, Memorial Sloan Kettering Cancer Center
Videos
03/30/2022
Vivian Strong, MD, discusses emerging treatments for gastric cancers in terms of surgical approaches, presented at the 2022 Great Debates and Updates in Gastrointestinal Malignancies meeting.
Vivian Strong, MD, discusses emerging treatments for gastric cancers in terms of surgical approaches, presented at the 2022 Great Debates and Updates in Gastrointestinal Malignancies meeting.
Vivian Strong, MD, discusses...
03/30/2022
Oncology
Dr Gibson
Videos
03/29/2022
Michael Gibson, MD, PhD, shares an overview of novel breakthroughs and progress with HER2 and immunotherapy targets to treat esophageal gastric cancer at the 2022 GDU GI Meeting.
Michael Gibson, MD, PhD, shares an overview of novel breakthroughs and progress with HER2 and immunotherapy targets to treat esophageal gastric cancer at the 2022 GDU GI Meeting.
Michael Gibson, MD, PhD, shares...
03/29/2022
Oncology
Dr Lieu
Podcasts
03/29/2022
Christopher Lieu, MD, University of Colorado, shares insights to how ctDNA can detect MRD and determine genomic characterization of tumors in CRC at the 2022 GDU GI Meeting.
Christopher Lieu, MD, University of Colorado, shares insights to how ctDNA can detect MRD and determine genomic characterization of tumors in CRC at the 2022 GDU GI Meeting.
Christopher Lieu, MD, University...
03/29/2022
Oncology
morris
Videos
03/26/2022
Van Morris, MD, MD Anderson Cancer Center, discusses KRAS G12C mutated colorectal cancer at the 2022 GDU GI Meeting.
Van Morris, MD, MD Anderson Cancer Center, discusses KRAS G12C mutated colorectal cancer at the 2022 GDU GI Meeting.
Van Morris, MD, MD Anderson...
03/26/2022
Oncology
News
03/26/2022
Cathy Eng, MD, FACP, FASCO, argued for VEGF therapy versus anti-EGFR inhibition in a debate with Dr Kasi at the 2022 GDU GI conference in New York, NY.
Cathy Eng, MD, FACP, FASCO, argued for VEGF therapy versus anti-EGFR inhibition in a debate with Dr Kasi at the 2022 GDU GI conference in New York, NY.
Cathy Eng, MD, FACP, FASCO,...
03/26/2022
Oncology
News
03/26/2022
Pashtoon M. Kasi, MD, MS, argued for EGFR inhibitors as a superior first-line treatment vs VEGF in a debate with Cathy Eng, MD, FACP, FASCO, at the 2022 Great Debates and Updates in GI Malignancies meeting.
Pashtoon M. Kasi, MD, MS, argued for EGFR inhibitors as a superior first-line treatment vs VEGF in a debate with Cathy Eng, MD, FACP, FASCO, at the 2022 Great Debates and Updates in GI Malignancies meeting.
Pashtoon M. Kasi, MD, MS, argued...
03/26/2022
Oncology
dr m
Videos
03/26/2022
Van Morris, MD, MD Anderson Cancer Center, talks approaches in treating patients with BRAF and RAS mutant colorectal cancer at the 2022 GDU GI Meeting. 
Van Morris, MD, MD Anderson Cancer Center, talks approaches in treating patients with BRAF and RAS mutant colorectal cancer at the 2022 GDU GI Meeting. 
Van Morris, MD, MD Anderson...
03/26/2022
Oncology
dr b
Videos
03/26/2022
In a debate at the 2022 Great Debates and Updates in Gastrointestinal Malignancies meeting, Daniel Brown, MD, FSIR, Vanderbilt University Medical Center, argued in favor of liver-directed therapy for patients with cholangiocarcinoma.
In a debate at the 2022 Great Debates and Updates in Gastrointestinal Malignancies meeting, Daniel Brown, MD, FSIR, Vanderbilt University Medical Center, argued in favor of liver-directed therapy for patients with cholangiocarcinoma.
In a debate at the 2022 Great...
03/26/2022
Oncology
dr s
Videos
03/26/2022
J. Joshua Smith, MD, PhD, FACS, Memorial Sloan Kettering Cancer Center, highlights the nonoperative management of rectal cancer.
J. Joshua Smith, MD, PhD, FACS, Memorial Sloan Kettering Cancer Center, highlights the nonoperative management of rectal cancer.
J. Joshua Smith, MD, PhD, FACS,...
03/26/2022
Oncology
dr smith
Videos
03/26/2022
J. Joshua Smith, MD, PhD, FACS, Memorial Sloan Kettering Cancer Center, discusses short-course vs long-course radiation therapy in rectal cancer, presented at the 2022 GDI GI Meeting.
J. Joshua Smith, MD, PhD, FACS, Memorial Sloan Kettering Cancer Center, discusses short-course vs long-course radiation therapy in rectal cancer, presented at the 2022 GDI GI Meeting.
J. Joshua Smith, MD, PhD, FACS,...
03/26/2022
Oncology
Dr V
Videos
03/26/2022
Namrata Vijayvergia, MD, FACP, Fox Chase Cancer Center, discusses whether or not the role for HIPEC is necessary for cytoreductive surgery, a debate presented at the 2022 Great Debates and Updates in Gastrointestinal Malignancies.
Namrata Vijayvergia, MD, FACP, Fox Chase Cancer Center, discusses whether or not the role for HIPEC is necessary for cytoreductive surgery, a debate presented at the 2022 Great Debates and Updates in Gastrointestinal Malignancies.
Namrata Vijayvergia, MD, FACP,...
03/26/2022
Oncology
Dr V
Videos
03/25/2022
Namrata Vijayvergia, MD, Fox Chase Cancer Center, discusses standard observation in systematic therapy following metastatic resection, a debate presented at the 2022 GDU GI Annual Meeting.
Namrata Vijayvergia, MD, Fox Chase Cancer Center, discusses standard observation in systematic therapy following metastatic resection, a debate presented at the 2022 GDU GI Annual Meeting.
Namrata Vijayvergia, MD, Fox...
03/25/2022
Oncology
Dr Ilson Talks Current Role of Immunotherapy in GEJ, GI Cancer- Part I
Videos
03/24/2021
In part 1 of this video series, David Ilson, MD, PhD, reviews recent immunotherapy updates in GEJ/gastric cancer.
In part 1 of this video series, David Ilson, MD, PhD, reviews recent immunotherapy updates in GEJ/gastric cancer.
In part 1 of this video series,...
03/24/2021
Oncology
Dr Ilson Talks Current Role of Immunotherapy in GEJ, GI Cancer- Part II
Videos
03/24/2021
In part 2 of this video series, David Ilson, MD, PhD, discusses approvals and advancements in the immunotherapy space for GEJ/GI cancer.
In part 2 of this video series, David Ilson, MD, PhD, discusses approvals and advancements in the immunotherapy space for GEJ/GI cancer.
In part 2 of this video series,...
03/24/2021
Oncology
Early On-Set CRC: A Biologically Distinct Threat? - Part II
Videos
03/15/2021
In part 2 of this series, Andrea Cercek, MD, discusses the clinical findings, molecular drivers/alterations, and further research for "Early On-Set Colorectal Cancer: A Biologically Distinct Threat?".
In part 2 of this series, Andrea Cercek, MD, discusses the clinical findings, molecular drivers/alterations, and further research for "Early On-Set Colorectal Cancer: A Biologically Distinct Threat?".
In part 2 of this series, Andrea...
03/15/2021
Oncology
Conference Insider
10/24/2020
Julio Garcia-Aguilar, MD, PhD, provided insight on how nonoperative management of rectal cancer is evolving at the virtual 2020 Great Debates & Updates in Gastrointestinal Malignancies meeting.
Julio Garcia-Aguilar, MD, PhD, provided insight on how nonoperative management of rectal cancer is evolving at the virtual 2020 Great Debates & Updates in Gastrointestinal Malignancies meeting.
Julio Garcia-Aguilar, MD, PhD,...
10/24/2020
Oncology
Rachna Shroff, MD, Discusses Novel and Targeted Therapies in Biliary Cancer
Videos
10/23/2020
Dr Shroff highlights novel and targeted biliary cancer therapies at the virtual 2020 Great Debates & Updates in GI Malignancies meeting.
Dr Shroff highlights novel and targeted biliary cancer therapies at the virtual 2020 Great Debates & Updates in GI Malignancies meeting.
Dr Shroff highlights novel and...
10/23/2020
Oncology
Debates and Updates in Treating Esophageal and GEJ Cancers
Conference Insider
10/23/2020
David Ilson, MD, PhD, discusses immunotherapy trial data as well as treatment debates in the esophageal and GEJ cancer space, at the virtual 2020 Great Debates and Updates in GI Malignancies meeting.
David Ilson, MD, PhD, discusses immunotherapy trial data as well as treatment debates in the esophageal and GEJ cancer space, at the virtual 2020 Great Debates and Updates in GI Malignancies meeting.
David Ilson, MD, PhD, discusses...
10/23/2020
Oncology
News
09/26/2020
At the Great Debates & Updates in GI Malignancies, Scott Kopetz, MD, PhD, participated in a lively debate on comprehensive molecular panel testing for GI Cancers, and spoke in favor of it.
At the Great Debates & Updates in GI Malignancies, Scott Kopetz, MD, PhD, participated in a lively debate on comprehensive molecular panel testing for GI Cancers, and spoke in favor of it.
At the Great Debates & Updates...
09/26/2020
Oncology
Current and Emerging Therapy Options in Pancreatic Cancer
Videos
09/26/2020
Jordan Berlin, MD, shares an overview of new treatment options and trials in pancreatic cancer at the virtual 2020 Great Debates and Updates in GI Malignancies meeting.
Jordan Berlin, MD, shares an overview of new treatment options and trials in pancreatic cancer at the virtual 2020 Great Debates and Updates in GI Malignancies meeting.
Jordan Berlin, MD, shares an...
09/26/2020
Oncology
Jordan Berlin, MD, Provides Highlights of Hot Topics at the 2020 Virtual GDU GI Meeting
Videos
09/25/2020
Dr Berlin highlights his favorite part of the Great Debates and Updates in GI Malignancies and gives attendees a taste of what's to come at this year's virtual meeting.
Dr Berlin highlights his favorite part of the Great Debates and Updates in GI Malignancies and gives attendees a taste of what's to come at this year's virtual meeting.
Dr Berlin highlights his...
09/25/2020
Oncology
Petros Grivas, MD, PhD, Discusses COVID-19 Risks in Patients With Cancer
Videos
09/23/2020
Petros Grivas, MD, PhD, Seattle Cancer Care Alliance, discusses the COVID-19 Cancer Consortium and developing a survey to evaluate risk factors in patients with cancer.
Petros Grivas, MD, PhD, Seattle Cancer Care Alliance, discusses the COVID-19 Cancer Consortium and developing a survey to evaluate risk factors in patients with cancer.
Petros Grivas, MD, PhD, Seattle...
09/23/2020
Oncology
Dr Lyman and Dr Desai Talk COVID-19, Cancer Care, and the CCC19 Initiative
Videos
08/18/2020
Aakash Desai, MD, MPH, and Gary Lyman, MD, MPH, discuss the CCC19 initiative and how COVID-19 has affected cancer care in the United States.
Aakash Desai, MD, MPH, and Gary Lyman, MD, MPH, discuss the CCC19 initiative and how COVID-19 has affected cancer care in the United States.
Aakash Desai, MD, MPH, and Gary...
08/18/2020
Oncology
Recent Advancements in the Treatment of Oligometastatic Cancer
Videos
08/15/2020
Christopher Crane, MD, Memorial Sloan Kettering Cancer Center, New York, NY discusses proof of principle for treating oligometastatic colorectal cancer at the virtual 2020 Great Debates and Updates in GI Malignancies.
Christopher Crane, MD, Memorial Sloan Kettering Cancer Center, New York, NY discusses proof of principle for treating oligometastatic colorectal cancer at the virtual 2020 Great Debates and Updates in GI Malignancies.
Christopher Crane, MD, Memorial...
08/15/2020
Oncology
Noam VanderWalde, MD, On Using Short-Course RT for Rectal Cancer, Upcoming Clinical Trials
Videos
08/14/2020
Noam Vanderwalde, MD, shares benefits of short- vs long-course RT for treating rectal cancer, and discusses upcoming trials to look out for.
Noam Vanderwalde, MD, shares benefits of short- vs long-course RT for treating rectal cancer, and discusses upcoming trials to look out for.
Noam Vanderwalde, MD, shares...
08/14/2020
Oncology
Conference Insider
08/14/2020
At the virtual Great Debates & Updates in GI Malignancies, Dr Ku provided an overview of new non-immunotherapy targets and drugs in the GI cancer space.
At the virtual Great Debates & Updates in GI Malignancies, Dr Ku provided an overview of new non-immunotherapy targets and drugs in the GI cancer space.
At the virtual Great Debates &...
08/14/2020
Oncology
News
08/10/2020
At the virtual 2020 Great Debates and Updates in GI Malignancies, experts in the oncology space will discuss and debate advancements in therapies for GI cancers.
At the virtual 2020 Great Debates and Updates in GI Malignancies, experts in the oncology space will discuss and debate advancements in therapies for GI cancers.
At the virtual 2020 Great...
08/10/2020
Oncology
Christopher Crane, MD, Debates Benefits of Long- vs Short-Course RT for Rectal Cancer
Podcasts
07/14/2020
Christopher Crane, MD, debates the benefits of long-course radiation therapy over short-course for treatment of rectal cancer at the virtual 2020 Great Debates and Updates in GI Malignancies meeting.
Christopher Crane, MD, debates the benefits of long-course radiation therapy over short-course for treatment of rectal cancer at the virtual 2020 Great Debates and Updates in GI Malignancies meeting.
Christopher Crane, MD, debates...
07/14/2020
Oncology
How I Practice Now: Radiation Oncology Amid the COVID-19 Pandemic
Videos
04/10/2020
Noam VanderWalde, MD, MS, discusses how the COVID-19 pandemic is affecting the treatment of patients with cancer receiving RT.
Noam VanderWalde, MD, MS, discusses how the COVID-19 pandemic is affecting the treatment of patients with cancer receiving RT.
Noam VanderWalde, MD, MS,...
04/10/2020
Oncology
Navigating Cancer Care During the COVID-19 Pandemic
Videos
04/05/2020
Ghassan Abou-Alfa, MD, talks about uncertainty brought on by the COVID-19 pandemic, and what this means for cancer treatment and research going forward.
Ghassan Abou-Alfa, MD, talks about uncertainty brought on by the COVID-19 pandemic, and what this means for cancer treatment and research going forward.
Ghassan Abou-Alfa, MD, talks...
04/05/2020
Oncology
How I Practice Now: The Vital Role of Telemedicine During the COVID-19 Pandemic
Videos
03/26/2020
Ghassan Abou-Alfa, MD, discusses the ins and outs of telemedicine use and importance of operational preparedness in the cancer setting during the COVID-19 pandemic.
Ghassan Abou-Alfa, MD, discusses the ins and outs of telemedicine use and importance of operational preparedness in the cancer setting during the COVID-19 pandemic.
Ghassan Abou-Alfa, MD, discusses...
03/26/2020
Oncology

Advertisement

Advertisement

Advertisement

Advertisement